CDC Vital Signs – launched July 2010

Posted on July 8, 2010. Filed under: Health Status, Public Hlth & Hlth Promotion | Tags: , , |

CDC Vital Signs

“CDC Vital Signs is a new series of MMWR reports that will announce the latest results for key public health indicators.

Most adults are getting recommended breast and colorectal cancer screenings. Yet a new CDC report says more than 22 million adults have not had screening tests for colorectal cancer, and more than 7 million women have not had a recent mammogram to screen for breast cancer as recommended. This CDC report also points out why more people need to get tested for colorectal and breast cancer and what can be done to increase screening.”

Read Full Post | Make a Comment ( None so far )

CDC to Monitor Reactions and Errors Associated with Blood Transfusions – 18 February 2010

Posted on February 22, 2010. Filed under: Clin Governance / Risk Mgmt / Quality, Haematology, Pathology, Patient Safety | Tags: , , |

CDC to Monitor Reactions and Errors Associated with Blood Transfusions – 18 February 2010

Extracts from the CDC press release:

“The Centers for Disease Control and Prevention has launched the first national surveillance system to monitor adverse events in patients who receive blood transfusions. CDC is encouraging healthcare facilities across the country to enroll in this new surveillance system, which was designed to improve patient safety.

By having a coordinated national network, CDC can summarize national data to understand better how to prevent adverse transfusion events such as reactions to blood products, medical errors, and process problems. The system, called the Hemovigilance Module, is part of CDC’s National Healthcare Safety Network (NHSN). NHSN is an Internet-based surveillance system that allows healthcare-associated infection data to be tracked and analyzed to allow CDC and healthcare facilities to maximize prevention efforts. The Hemovigilance Module was developed by CDC in collaboration with AABB, an international association representing organizations involved in transfusion and cellular therapies.”  …..

“Hospitals will submit data confidentially to CDC through the Hemovigilance Module. CDC will review the national data in collaboration with AABB and other partners to help identify ways to improve the safety of blood transfusion. Previously, transfusion-related events were monitored by facilities on their own. Now, hospitals that join the Hemovigilance Module will have access to standardized data analysis tools, as well as an opportunity to see how their data compare to other hospitals throughout the United States.”  …

“CDC provides the module at no cost to hospitals and healthcare facilities. The agency also provides participating facilities with training and ongoing user support at no cost to the facilities.”

For more information, please visit the National Healthcare Safety Network (NHSN) .

Read Full Post | Make a Comment ( None so far )

Liked it here?
Why not try sites on the blogroll...